Abstract
Abnormalities in plasma lipoprotein metabolism are mostly based upon specific gene defects. Gene therapy forms the ultimate treatment of these disorders. The present data, focused upon the treatment of apolipoprotein E (ApoE) and LDL-receptor deficiency are the first examples of and analysis of gene-replacement on the development atherosclerotic lesions.
Inactivation of the apoE gene in mice leads to a prominent increase in serum cholesterol and triglyceride levels and the development of premature atherosclerosis. The role of monocyte/macrophage-derived apoE in atherogenesis was assessed by bone marrow transplantation in apoE-deficient mice, using donor bone marrow of wild-type mice. Quantitation of atherosclerotic lesions in the aortic root, after 4 months of “Western-type” diet, revealed that the mean lesion area was approximately 10-fold smaller in mice tranplanted with bone marrow from wild-type donors as compared to control apoE-deficient mice.
The influence of apoE gene-dosage on serum lipid concentrations was determined by transplantation with homozygous apoE-deficient heterozygous apoE-deficient and wild-type bone marrow. The concentration of apoE, detected in serum, was found to be gene-dosage dependent, being 3.52 ± 0.74%, 1.87 ± 74% and 0% of normal in transplanted mice receiving either wild-type, heterozygote apoE-deficient, or homozygous apoE-deficient bone marrow, respectively. These low concentrations of apoE nevertheless reduced serum cholesterol levels dramatically due to a reduction of VLDL, and to a lesser extent, of LDL, while HDl levels were slightly raised.
The relative importance of the LDLR on macrophages for lipoprotein metabolism and atherogenesis was assessed by transplantation of LDLR knockout (-/-) mice with bone marrow of normal C57BI mice. The transplantation resulted in a decrease can almost completely be attributed to a decrease in LDL-cholesterol. The specific lowering of LDL-cholesterol was more pronounced 4 weeks after transplantation than 12 weeks after transplantation.
Quantitation of atherosclerotic lesions of mice fed a 1% cholesterol diet for 6 months, revealed that there were no differences in mean lesion area between mice transplanted with wild-type bone marrow or LDLR-/- bone marrow. We anticipate that in the LDLR-/- mice transplanted with wild-type bone marrow, the LDLR is down-regulated by the relatively high concentrations of circulating cholesterol. In vitro incubations of peritoneal microphages with 125I-LDL indicated that the LDLR of these cells could be downregulated by 25-OH cholesterol. PEritoneal macrophages isolated from LDLR-/- mice tranplanted with wild-type bone marrow, in contrast to those tranplanted woth LDLR-/- bone marrow, were able to degrade 125I-LDL, indicating that the capaity to express functional LDLR was achieved. In conclusion, introduction of the LDLR in LDLR-/- mice via bone marrow transplantation resulted in a relatively modest decrease of LDL-cholesterol levels in apoE-deficient mice. Atherosclerotic lesions in apoE deficient mice were 10-fold smaller in mice transplanted with bone marrow from wild-type donor, establishing the anti-atherogenic role of macrophage-associated apoE production.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–30.
Moestrup SK. The α2-macroglobulio receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochim Biophys Acta. 1994;1197:197–213.
Krieger M, Herz J. Structures and functions of multiligand receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;62:601–37.
Rail jr SC, Mahley RW. The role of apolipoprotrein E genetic variants in lipoprotein disorders. J Int Med. 1992;231:653–9.
Havekes L, De Wit E, Gevers Leuven J et al, Beisiegel U. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E, associated with familial type III hyperlipoproteinemia. Hum Genet. 1986;73:157–63.
Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rall SC Jr. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem. 1992;267:1962–8.
Ghiselli G, Schaefer EJ, Gascon P, Brewer HB Jr. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science. 1981;214:1239–41.
Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer jr HB. Familial apolipoprotein E deficiency. J Clin Invest. 1986;78:1206-19.
Cladaras C, Hadzopoulou-Cladaras M, Felber BK, Pavlakis G, Zannis VI. The molecular basis of familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. J Biol Chem. 1987;262:2310-5.
Lohse P, Brewer III HB, Meng MS, Skarlatos SI, LaRosa JC, Brewer HB Jr. Familial apolipoprotein E deficiency and type III hyperlipoproteinemia due to a premature stop codon in the apolipoprotein E gene. J Lipid Res. 1992;33:1583–90.
Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468–71.
Plump AS, Smith JD, Hayek T et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343–53.
Van Ree JH, Van den Broek WJAA, Dahlmans VEH et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994;111:25–37.
Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1:445–66.
Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Stanbury JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS, ed. The metabolic basis of inherited diseases. New York: McGraw-Hill; 1983:622–730.
Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92:883–93.
Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 1994;93:1885–93.
Nagelkerke JF, van Berkel ThJC. Rapid transport of fatty acids from rat liver endothelial to parenchymal cells after uptake of cholesterylester labeled acetylated LDL. Biochim Biophys Acta. 1986;875:593–8.
Pieters MN, Esbach S, Schouten D, Brouwer A, Knook DL, van Berkel ThJC. Cholesterylesters from oxidized LDL are in vivo rapidly hydrolysed in rat Kupffer cells and transported to liver parenchymal cells and bile. Hepatology. 1994;19:1459–67.
Goldstein JL, Brown MS. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane bound proteins that regulate the plasma cholesterol. J Lipid Res. 1984;1450–61.
Tangirala RK , Rubin EM. Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E deficient mice. J Lipid Res. 1995;35:385-98.22.
Wilson JM, Johnston DE, Jefferson DM, Mulligan RC. Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA. 1988;85:4421–5.
Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM, In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem. 1994;18:13695–702.
Grossman M, Raper SE, Kozarsky K et al. Successful ex vivo gene therapy directed to fiver in a patient with familial hypercholesterolaemia. Nature Genet. 1994;6:335–41.
Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA. 1993; 2812-6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Kluwer Academic Publisher
About this chapter
Cite this chapter
van Berkel, T.J.C., van Eck, M., Herijgers, N., Hoogerbrugge, P.M., Groot, P.H.E. (1997). Modulation of Arteriosclerosis by Gene-Therapy. In: van der Wall, E.E., Cats, V.M., Baan, J. (eds) Vascular Medicine. Developments in Cardiovascular Medicine, vol 197. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0037-0_12
Download citation
DOI: https://doi.org/10.1007/978-94-009-0037-0_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6505-4
Online ISBN: 978-94-009-0037-0
eBook Packages: Springer Book Archive